Prevalence and incidence of type 2 diabetes mellitus by sex in 1990 and 2023, with absolute change (per 100,000 population).
| Indicator | Sex | 1990 | 2023 | Absolute change (1990–2023) |
|---|---|---|---|---|
| Prevalence | Male | 2,817.8 (2,505.6–3,121.2) | 3,013.7 (2,710.7–3,311.3) | +195.9 |
| Prevalence | Female | 2,709.1 (2,417.2–3,005.6) | 2,912.9 (2,621.0–3,189.6) | +203.8 |
| Incidence | Male | 163.5 (147.4–179.4) | 171.4 (153.9–187.7) | +7.9 |
| Incidence | Female | 145.1 (130.0–160.6) | 151.8 (138.2–165.2) | +6.7 |
Values are age-standardized rates per 100,000 population with 95% uncertainty intervals (UI).
The supplementary tables for this article are available at: https://www.explorationpub.com/uploads/Article/file/1001416_sup_1.pdf.
We are grateful for the collaboration between the National Data Management and Analytics Centre (NDMC) at the Ethiopian Public Health Institutes, the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, and the GBD Collaborators Network of Experts, and Hawassa University for the Ethiopia national and subnational burden of disease analysis.
KTB, WA, JB, and AM: Conceptualization. KTB, WA, JB, YAJ, SM, ST, A Walker, MN, A Worku, TM, AEA, AY: Data curation. KTB, WA, AEA: Formal analysis. WA, JB, YAJ, SM, ST, A Walker, MN, A Worku, TM, AEA, AY, CM: Investigation. KTB, A Walker, MN, AM, A Worku, TM, AEA, AY: Methodology. AM: Project administration. A Walker, MN, AM: Resources. KTB, A Walker, MN: Software. A Walker, MN, A Worku: Supervision. A Walker, MN, AM: Validation. KTB, CM: Visualization. KTB, A Worku: Writing—original draft. KTB. WA. JB. YAJ. SM. ST. A Walker. MN. A Worku. TM. AEA. AY. CM. AM: Writing—review & editing. All authors read and approved the submitted version.
The authors declare that they have no competing interests.
The manuscript used open-access GBD 2023 secondary data from the Institute for Health Metrics and Evaluation (IHME), University of Washington Health Data portal. As secondary, de-identified data were used, formal ethics approval was not required.
As secondary, de-identified data were used, informed consent was not required.
Not applicable.
The datasets generated and/or analyzed during the study are available in the IHME Global Burden of Disease Data Exchange repository and can be accessed directly from: http://ghdx.healthdata.org/gbd-results-tool. The data will be made available, without undue reservation, to any qualified researcher.
The Bill and Melinda Gates Foundation funds national and subnational burden of disease studies (Grant Number: OPP1152504). The funder had no role in study design, data collection, analysis, interpretation, or writing of the report.
© The Author(s) 2026.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.